PREGNANCY OUTCOME IN PERIPARTUM CARDIOMYOPATHY

Background:Peripartum cardiomyopathy(PPCM) is characterized by the onset of heart failure due to left ventricular systolic dysfunction in late pregnancy or shortly after delivery. The incidence of PPCM varies widely globally, with reports ranging from 1 in 100-15000 pregnancies This study aims to evaluate the incidence, clinical characteristics, and outcomes of PPCM in a cohort of women at Basaweshwara General and Teaching Hospital, Kalaburgi.

Methods:A retrospective observational study was conducted over one year (January 1 to December 31, 2023). Inclusion criteria were based on NHLBI standards for diagnosing PPCM, while patients with preexisting cardiac conditions, liver disorders, and malignancies were excluded. Data were collected from hospital records, focusing on demographics, clinical presentations,echocardiographic findings, complications, and outcomes. Statistical analysis was performed using SPSS version22.

Results:Among 2,200 deliveries, 12 cases of PPCM were identified, yielding an incidence of 0.55%. The mean age of affected women was 26.33 years, with 66% being primigravida. A significant proportion (58.33%) presented with hypertensive disorders.Maternal outcomes included a 25% mortality rate and high rates of cesarean delivery (83.33%).Neonatal outcomes were concerning, with 58.33% of infants requiring NICU admission and 16.66% experiencing intrauterine death.

Conclusion:PPCM poses substantial risks to maternal and fetal health, particularly in younger and first-time mothers. Identifying women with risk factors such as hypertensive disorders and anemia is crucial for optimizing care and improving outcomes. Enhanced monitoring and intervention strategies are necessary to address the complexities of PPCM in pregnancy.